Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (831-840 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|March 22, 2000
Prostate-seminal vesicle cancers induced in noble ratsM Pollard, W R Wolter, L Sun
The Prostate|February 7, 2001
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat modelM Lein, K Jung, D K Le, et al.
The Prostate|July 6, 2000
Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distributionA Goulas, D G Hatzichristou, G Karakiulakis, et al.
The Prostate|July 6, 2000
Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell culturesT S Schwab, T Stewart, J Lehr, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
The Prostate|July 4, 2001
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosinK Keledjian, A Borkowski, G Kim, et al.
The Prostate|July 4, 2001
Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancerL M Chen, G B Hodge, L A Guarda, et al.
The Prostate|July 4, 2001
Calcium, dairy products, and the risk of prostate cancerA Tavani, S Gallus, S Franceschi, et al.
The Prostate|July 4, 2001
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessingS R Denmeade, J Lövgren, S R Khan, et al.
The Prostate|September 6, 2001
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cellsM Burchardt, T Burchardt, A Shabsigh, et al.
Pageof 609

Showing results (831-840 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|March 22, 2000
Prostate-seminal vesicle cancers induced in noble ratsM Pollard, W R Wolter, L Sun
The Prostate|February 7, 2001
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat modelM Lein, K Jung, D K Le, et al.
The Prostate|July 6, 2000
Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distributionA Goulas, D G Hatzichristou, G Karakiulakis, et al.
The Prostate|July 6, 2000
Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell culturesT S Schwab, T Stewart, J Lehr, et al.
The Prostate|July 6, 2000
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathwaysA Plonowski, A V Schally, J L Varga, et al.
The Prostate|July 4, 2001
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosinK Keledjian, A Borkowski, G Kim, et al.
The Prostate|July 4, 2001
Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancerL M Chen, G B Hodge, L A Guarda, et al.
The Prostate|July 4, 2001
Calcium, dairy products, and the risk of prostate cancerA Tavani, S Gallus, S Franceschi, et al.
The Prostate|July 4, 2001
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessingS R Denmeade, J Lövgren, S R Khan, et al.
The Prostate|September 6, 2001
Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cellsM Burchardt, T Burchardt, A Shabsigh, et al.
Pageof 609